source
- Four questions on new safety warnings for Neurocrine’s Vykat XRA group of experts on Prader-Willi syndrome has sounded the alarm on side effects and deaths that may be connected to Neurocrine Biosciences’ medicine Vykat XR. The treatment has been linked to sev…Endpoints · 19m ago↗ source
- Deaths reported after treatment with Neurocrine’s approved Prader-Willi drugReports of seven deaths in patients who had taken Neurocrine Biosciences’ Vykat and the official termination of Aardvark Therapeutics’ Phase 3 trial after cardiac complications marked a tough day f…BioSpace · 3h ago↗ source
- 7 companies hiring in North Carolina nowLooking for a biopharma job in North Carolina? Job postings in the area have increased. Here are seven companies with open roles.